stocksfeed.ai
← Back to news feed

TEVA overview

TEVA
Teva Pharmaceutical Industries
42.23
USD
-1.94 (-4.39%)since Nov 16, 2026

News about TEVA

3 stories shown

Glenview Capital's Q3 13F filing reveals increased stakes in Meta and Teva, reductions in CVS and Block, and full exits from Dick's Sporting Goods and STM.

Seeking Alpha
View original
TEVAregulation

The FDA approved Teva Pharmaceutical Industries' IGALMI sublingual film for at-home use in treating acute agitation associated with schizophrenia and bipolar disorder.

Benzinga
View original
TEVAproduct launch

Teva received FDA approval for an at-home indication of Igalmi to treat agitation associated with schizophrenia and other disorders.

Seeking Alpha
View original